Cardiovascular Magnetic Resonance Imaging of Non-ischaemic Heart Disease: Established and Emerging Applications

Heart Lung and Circulation

Volumn 19, Issue 3, 2010, Pages 117-132

  Bohl, Steffen ^a,b   Schulz Menger, Jeanette ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ARVC D; Cardiovascular magnetic resonance; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Inflammatory disease; Nonischaemic cardiomyopathy; NonIschaemic heart disease; Systemic disorder

Indexed keywords

ALPHA GALACTOSIDASE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GADOLINIUM;

ARTICLE; CHURG STRAUSS SYNDROME; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FABRY DISEASE; HEART AMYLOIDOSIS; HEART DISEASE; HEART EDEMA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE QUALITY; IRON OVERLOAD; MYOCARDITIS; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; SYSTEMIC LUPUS ERYTHEMATOSUS; TAKOTSUBO CARDIOMYOPATHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AMYLOIDOSIS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CHURG-STRAUSS SYNDROME; HEART DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING, CINE; TAKOTSUBO CARDIOMYOPATHY;

EID: 77649235126     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2009.11.005     Document Type: Article

References (86)

1. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 6 (2005) e1-e82
2. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., Baughman K.L., and Kasper E.K. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. New Engl J Med 342 15 (2000) 1077-1084
3. Gerull B., Heuser A., Wichter T., Paul M., Basson C.T., McDermott D.A., Lerman B.B., Markowitz S.M., Ellinor P.T., MacRae C.A., Peters S., Grossmann K.S., Drenckhahn J., Michely B., Sasse-Klaassen S., Birchmeier W., Dietz R., Breithardt G., Schulze-Bahr E., and Thierfelder L. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36 11 (2004) 1162-1164
4. Heuser A., Plovie E.R., Ellinor P.T., Grossmann K.S., Shin J.T., Wichter T., Basson C.T., Lerman B.B., Sasse-Klaassen S., Thierfelder L., MacRae C.A., and Gerull B. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 79 6 (2006) 1081-1088
5. McKenna W.J., Thiene G., Nava A., Fontaliran F., Blomstrom-Lundqvist C., Fontaine G., and Camerini F. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71 3 (1994) 215-218
6. Tandri H., Daya S.K., Nasir K., Bomma C., Lima J.A., Calkins H., and Bluemke D.A. Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol 98 12 (2006) 1660-1664
7. Alfakih K., Plein S., Thiele H., Jones T., Ridgway J.P., and Sivananthan M.U. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17 3 (2003) 323-329
8. Tandri H., Macedo R., Calkins H., Marcus F., Cannom D., Scheinman M., Daubert J., Estes III M., Wilber D., Talajic M., Duff H., Krahn A., Sweeney M., Garan H., and Bluemke D.A. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J 155 1 (2008) 147-153
9. Tandri H., Castillo E., Ferrari V.A., Nasir K., Dalal D., Bomma C., Calkins H., and Bluemke D.A. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 48 11 (2006) 2277-2284
10. Casolo G., Minneci S., Manta R., Sulla A., Del Meglio J., Rega L., and Gensini G. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement. Am Heart J 151 1 (2006) 101-108
11. McCrohon J.A., Moon J.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J., and Pennell D.J. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 1 (2003) 54-59
12. Iles L., Pfluger H., Phrommintikul A., Cherayath J., Aksit P., Gupta S.N., Kaye D.M., and Taylor A.J. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52 19 (2008) 1574-1580
13. Nazarian S., Bluemke D.A., Lardo A.C., Zviman M.M., Watkins S.P., Dickfeld T.L., Meininger G.R., Roguin A., Calkins H., Tomaselli G.F., Weiss R.G., Berger R.D., Lima J.A., and Halperin H.R. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112 18 (2005) 2821-2825
14. Assomull R.G., Prasad S.K., Lyne J., Smith G., Burman E.D., Khan M., Sheppard M.N., Poole-Wilson P.A., and Pennell D.J. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 10 (2006) 1977-1985
15. Klaassen S., Probst S., Oechslin E., Gerull B., Krings G., Schuler P., Greutmann M., Hurlimann D., Yegitbasi M., Pons L., Gramlich M., Drenckhahn J.D., Heuser A., Berger F., Jenni R., and Thierfelder L. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117 22 (2008) 2893-2901
16. Jenni R., Oechslin E., Schneider J., Attenhofer Jost C., and Kaufmann P.A. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart (Br Card Soc) 86 6 (2001) 666-671
17. Petersen S.E., Selvanayagam J.B., Wiesmann F., Robson M.D., Francis J.M., Anderson R.H., Watkins H., and Neubauer S. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46 1 (2005) 101-105
18. Alsaileek A.A., Syed I., Seward J.B., and Julsrud P. Myocardial fibrosis of left ventricle: magnetic resonance imaging in noncompaction. J Magn Reson Imaging 27 3 (2008) 621-624
19. Bohl S., Wassmuth R., Abdel-Aty H., Rudolph A., Messroghli D., Dietz R., and Schulz-Menger J. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 24 6 (2008) 597-607
20. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92 4 (1995) 785-789
21. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 10 (2002) 1308-1320
22. Rickers C., Wilke N.M., Jerosch-Herold M., Casey S.A., Panse P., Panse N., Weil J., Zenovich A.G., and Maron B.J. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112 6 (2005) 855-861
23. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., and McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36 7 (2000) 2212-2218
24. Olivotto I., Maron M.S., Autore C., Lesser J.R., Rega L., Casolo G., De Santis M., Quarta G., Nistri S., Cecchi F., Salton C.J., Udelson J.E., Manning W.J., and Maron B.J. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 52 7 (2008) 559-566
25. Schulz-Menger J., Abdel-Aty H., Busjahn A., Wassmuth R., Pilz B., Dietz R., and Friedrich M.G. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 8 5 (2006) 741-746
26. van Dockum W.G., ten Cate F.J., ten Berg J.M., Beek A.M., Twisk J.W., Vos J., Hofman M.B., Visser C.A., and van Rossum A.C. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43 1 (2004) 27-34
27. van Dockum W.G., Beek A.M., ten Cate F.J., ten Berg J.M., Bondarenko O., Gotte M.J., Twisk J.W., Hofman M.B., Visser C.A., and van Rossum A.C. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111 19 (2005) 2503-2508
28. Schulz-Menger J., Gross M., Messroghli D., Uhlich F., Dietz R., and Friedrich M.G. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 42 3 (2003) 513-518
29. Valeti U.S., Nishimura R.A., Holmes D.R., Araoz P.A., Glockner J.F., Breen J.F., Ommen S.R., Gersh B.J., Tajik A.J., Rihal C.S., Schaff H.V., and Maron B.J. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49 3 (2007) 350-357
30. Rudolph A., Abdel-Aty H., Bohl S., Boye P., Zagrosek A., Dietz R., and Schulz-Menger J. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53 3 (2009) 284-291
31. Abdel-Aty H., Cocker M., Strohm O., Filipchuk N., and Friedrich M.G. Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy. J Magn Reson Imaging 28 1 (2008) 242-245
32. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 9 (2003) 1561-1567
33. Adabag A.S., Maron B.J., Appelbaum E., Harrigan C.J., Buros J.L., Gibson C.M., Lesser J.R., Hanna C.A., Udelson J.E., Manning W.J., and Maron M.S. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 14 (2008) 1369-1374
34. Dote K., Sato H., Tateishi H., Uchida T., and Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 21 2 (1991) 203-214
35. Haghi D., Papavassiliu T., Hamm K., Kaden J.J., Borggrefe M., and Suselbeck T. Coronary artery disease in takotsubo cardiomyopathy. Circ J 71 7 (2007) 1092-1094
36. Haghi D., Fluechter S., Suselbeck T., Kaden J.J., Borggrefe M., and Papavassiliu T. Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy). Int J Cardiol 120 2 (2007) 205-211
37. Athanasiadis A., Vogelsberg H., Hauer B., Meinhardt G., Hill S., and Sechtem U. Transient left ventricular dysfunction with apical ballooning (tako-tsubo cardiomyopathy) in Germany. Clin Res Cardiol 95 6 (2006) 321-328
38. Wittstein I.S., Thiemann D.R., Lima J.A., Baughman K.L., Schulman S.P., Gerstenblith G., Wu K.C., Rade J.J., Bivalacqua T.J., and Champion H.C. Neurohumoral features of myocardial stunning due to sudden emotional stress. New Engl J Med 352 6 (2005) 539-548
39. Pavin D., Le Breton H., and Daubert C. Human stress cardiomyopathy mimicking acute myocardial syndrome. Heart (Br Card Soc) 78 5 (1997) 509-511
40. Prasad A., Lerman A., and Rihal C.S. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 155 3 (2008) 408-417
41. Mori H., Ishikawa S., Kojima S., Hayashi J., Watanabe Y., Hoffman J.I., and Okino H. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res 27 2 (1993) 192-198
42. Abdel-Aty H., Cocker M., and Friedrich M.G. Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol (2007)
43. Sharkey S.W., Lesser J.R., Zenovich A.G., Maron M.S., Lindberg J., Longe T.F., and Maron B.J. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 111 4 (2005) 472-479
44. Koeth O., Mark B., Kilkowski A., Layer G., Cornelius B., Kouraki K., Bauer T., Zahn R., Senges J., and Zeymer U. Clinical angiographic and cardiovascular magnetic resonance findings in consecutive patients with Takotsubo cardiomyopathy. Clin Res Cardiol 97 9 (2008) 623-627
45. Abdel-Aty H., Zagrosek A., Schulz-Menger J., Taylor A.J., Messroghli D., Kumar A., Gross M., Dietz R., and Friedrich M.G. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109 20 (2004) 2411-2416
46. Selvanayagam J.B., Hawkins P.N., Paul B., Myerson S.G., and Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50 22 (2007) 2101-2110
47. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. New Engl J Med 349 6 (2003) 583-596
48. Maceira A.M., Joshi J., Prasad S.K., Moon J.C., Perugini E., Harding I., Sheppard M.N., Poole-Wilson P.A., Hawkins P.N., and Pennell D.J. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 2 (2005) 186-193
49. Perugini E., Rapezzi C., Piva T., Leone O., Bacchi-Reggiani L., Riva L., Salvi F., Lovato L., Branzi A., and Fattori R. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (Br Card Soc) 92 3 (2006) 343-349
50. Moon J.C., Sachdev B., Elkington A.G., McKenna W.J., Mehta A., Pennell D.J., Leed P.J., and Elliott P.M. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24 23 (2003) 2151-2155
51. Moon J.C., Sheppard M., Reed E., Lee P., Elliott P.M., and Pennell D.J. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson. 8 3 (2006) 479-482
52. Imbriaco M., Spinelli L., Cuocolo A., Maurea S., Sica G., Quarantelli M., Pisani A., Liuzzi R., Cianciaruso B., Sabbatini M., and Salvatore M. MRI characterization of myocardial tissue in patients with Fabry's disease. AJR 188 3 (2007) 850-853
53. Prince M.R., Zhang H., Morris M., MacGregor J.L., Grossman M.E., Silberzweig J., DeLapaz R.L., Lee H.J., Magro C.M., and Valeri A.M. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248 3 (2008) 807-816
54. Modell B., Khan M., Darlison M., Westwood M.A., Ingram D., and Pennell D.J. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10 1 (2008) 42
55. Anderson L.J., Holden S., Davis B., Prescott E., Charrier C.C., Bunce N.H., Firmin D.N., Wonke B., Porter J., Walker J.M., and Pennell D.J. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22 23 (2001) 2171-2179
56. Hershko C. Iron loading and its clinical implications. Am J of Hematol 82 12 Suppl. (2007) 1147-1148
57. Anderson L.J., Westwood M.A., Holden S., Davis B., Prescott E., Wonke B., Porter J.B., Walker J.M., and Pennell D.J. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127 3 (2004) 348-355
58. Anderson L.J., Wonke B., Prescott E., Holden S., Walker J.M., and Pennell D.J. Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet 360 9332 (2002) 516-520
59. Cooper L.T., Baughman K.L., Feldman A.M., Frustaci A., Jessup M., Kuhl U., Levine G.N., Narula J., Starling R.C., Towbin J., and Virmani R. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116 19 (2007) 2216-2233
60. Kuhl U., Pauschinger M., Seeberg B., Lassner D., Noutsias M., Poller W., and Schultheiss H.P. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112 13 (2005) 1965-1970
61. Zagrosek A., Wassmuth R., Abdel-Aty H., Rudolph A., Dietz R., and Schulz-Menger J. Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis-a CMR study. J Cardiovasc Magn Reson 10 1 (2008) 19
62. Abdel-Aty H., Boye P., Zagrosek A., Wassmuth R., Kumar A., Messroghli D., Bock P., Dietz R., Friedrich M.G., and Schulz-Menger J. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45 11 (2005) 1815-1822
63. Zagrosek A., Abdel-Aty H., Boye P., Wassmuth R., Messroghli D., Utz W., Rudolph A., Bohl S., Dietz R., and Schulz-Menger J. Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. J Am Coll Cardiol Imaging 2 (2009) 131-138
64. Schulz-Menger J., Wassmuth R., Abdel-Aty H., Siegel I., Franke A., Dietz R., and Friedrich M.G. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart (Br Card Soc) 92 3 (2006) 399-400
65. Abdel-Aty H., Siegle N., Natusch A., Gromnica-Ihle E., Wassmuth R., Dietz R., and Schulz-Menger J. Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach. Lupus 17 6 (2008) 561-567
66. Gutberlet M., Spors B., Thoma T., Bertram H., Denecke T., Felix R., Noutsias M., Schultheiss H.P., and Kuhl U. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 246 2 (2008) 401-409
67. Mahrholdt H., Goedecke C., Wagner A., Meinhardt G., Athanasiadis A., Vogelsberg H., Fritz P., Klingel K., Kandolf R., and Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 10 (2004) 1250-1258
68. Mahrholdt H., Wagner A., Deluigi C.C., Kispert E., Hager S., Meinhardt G., Vogelsberg H., Fritz P., Dippon J., Bock C.T., Klingel K., Kandolf R., and Sechtem U. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114 15 (2006) 1581-1590
69. Churg J., and Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27 2 (1951) 277-301
70. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 2 (1994) 187-192
71. Noth I., Strek M.E., and Leff A.R. Churg-Strauss syndrome. Lancet 361 9357 (2003) 587-594
72. Mukherjee B., Chir B., Moon J.C., Sandrasagra M., and Pennell D.J. Endomyocardial fibrosis in Churg-Strauss syndrome. Clin Cardiol 27 1 (2004) 21
73. Chun W., Grist T.M., Kamp T.J., Warner T.F., and Christian T.F. Images in cardiovascular medicine. Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Circulation 110 3 (2004) e19
74. Smedema J.P., van Paassen P., van Kroonenburgh M.J., Snoep G., Crijns H.J., and Tervaert J.W. Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol 22 6 Suppl. 36 (2004) S75-78
75. Petersen S.E., Kardos A., and Neubauer S. Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Heart (Br Card Soc) 91 1 (2005) e9
76. Rosenberg M., Lorenz H.M., Gassler N., Katus H.A., and Frey N. Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS). Clin Res Cardiol 95 5 (2006) 289-294
77. Wassmuth R., Gobel U., Natusch A., Schneider W., Kettritz R., Dietz R., Luft F.C., and Schulz-Menger J. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J Card Fail 14 10 (2008) 856-860
78. Silverman K.J., Hutchins G.M., and Bulkley B.H. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58 6 (1978) 1204-1211
79. Smedema J.P., Snoep G., van Kroonenburgh M.P., van Geuns R.J., Cheriex E.C., Gorgels A.P., and Crijns H.J. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 128 3 (2005) 1629-1637
80. Okayama K., Kurata C., Tawarahara K., Wakabayashi Y., Chida K., and Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 107 2 (1995) 330-334
81. Futamatsu H., Suzuki J., Adachi S., Okada H., Otomo K., Ohara T., Hashimoto Y., Kakuta T., Iesaka Y., Yamaguchi H., Sakurada H., Sato A., Obayashi T., Niwa A., Hirao K., and Isobe M. Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Cardiovasc Imaging 22 3-4 (2006) 443-448
82. Roman M.J., Shanker B.A., Davis A., Lockshin M.D., Sammaritano L., Simantov R., Crow M.K., Schwartz J.E., Paget S.A., Devereux R.B., and Salmon J.E. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. New Engl J Med 349 25 (2003) 2399-2406
83. Asanuma Y., Oeser A., Shintani A.K., Turner E., Olsen N., Fazio S., Linton M.F., Raggi P., and Stein C.M. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. New Engl J Med 349 25 (2003) 2407-2415
84. Wijetunga M., and Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 113 5 (2002) 419-423
85. Edwards N.C., Ferro C.J., Townend J.N., and Steeds R.P. Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology (Oxford) 46 7 (2007) 1208-1209
86. O'Neill S.G., Woldman S., Bailliard F., Norman W., McEwan J., Isenberg D.A., Taylor A.M., and Rahman A. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis (2008)